NL-OMON30658已完成2 期
A MULTI-CENTER, RANDOMIZED, CROSS-OVER, DOUBLE-BLIND, THIRD PARTY OPEN, PLACEBO CONTROLLED, PILOT STUDY TO ASSESS THE URODYNAMIC EFFECTS OF MODIFIED RELEASE UK-369,003 IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS) - The effects of UK-369,003 MR on urodynamics in patients with LUTS
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •age <=> 40 years
- •LUTS with definition IPSS <=> 13 score
- •with clinical diagnosis of BPH
- •(see protocol page 13)
排除标准
- •prostate cancer
- •documentation of urine infection
- •use of certain medication(s) and/or operation(s)
- •(see protocol 13-16)
研究者
相似试验
进行中（未招募）
不适用
A MULTI-CENTER, RANDOMIZED, CROSS-OVER, DOUBLE-BLIND, THIRD PARTY OPEN, PLACEBO CONTROLLED, PILOT STUDY TO ASSESS THE URODYNAMIC EFFECTS OF MODIFIED RELEASE UK-369,003 IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS)EUCTR2006-004380-58-LVPfizer Limited, Ramsgate Road, Sandwich, Kent. UK. CT13 9NJ20
进行中（未招募）
1 期
A MULTI-CENTER, RANDOMIZED, CROSS-OVER, DOUBLE-BLIND, THIRD PARTY OPEN, PLACEBO CONTROLLED, PILOT STUDY TO ASSESS THE URODYNAMIC EFFECTS OF MODIFIED RELEASE UK-369,003 IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS)ower Urinary Tract SymptomsMedDRA version: 8.1Level: LLTClassification code 10024981Term: Lower urinary tract infectionEUCTR2006-004380-58-NLPfizer Limited20
进行中（未招募）
不适用
A MULTI-CENTER, RANDOMIZED, CROSS-OVER, DOUBLE-BLIND, THIRD PARTY OPEN, PLACEBO CONTROLLED, PILOT STUDY TO ASSESS THE URODYNAMIC EFFECTS OF MODIFIED RELEASE UK-369,003 IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS)ower Urinary Tract SymptomsMedDRA version: 8.1Level: LLTClassification code 10024981Term: Lower urinary tract infectionEUCTR2006-004380-58-CZPfizer Limited, Ramsgate Road, Sandwich, Kent. UK. CT13 9NJ20
进行中（未招募）
1 期
Evaluation of the Efficacy and Safety of MV140rinary Tract infectionMedDRA version: 20.0Level: LLTClassification code 10038140Term: Recurrent urinary tract infectionSystem Organ Class: 100000004862EUCTR2013-001838-17-GBSyner-Med (PP) Ltd240
进行中（未招募）
不适用
A MULTICENTER, RANDOMIZED, DOUBLE BLIND, DOUBLE-DUMMY PLACEBO- CONTROLLED PARALLEL-GROUP MULTIPLE DOSE STUDY OF THE EFFICACY AND SAFETY OF TACROLIMUS INHALATION AEROSOL IN PATIENTS WITH MODERATE PERSISTENT ASTHMA - Tacrolimus MDI Dose ResponseModerate persistent asthmaMedDRA version: 7.0Level: LLTClassification code 10003555EUCTR2004-001075-20-LTFujisawa GmbH400